Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company was founded in 2019 and is headquartered in Zurich, Switzerland.
XLS net income for the last half-year is 491.43 K EUR, while the previous report showed 22.34 M EUR of net income which accounts for −97.80% change. Track more XLIFE SCIENCES LTD. financial stats to get the full picture.
No, XLS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. XLIFE SCIENCES LTD. EBITDA is −2.77 M EUR, and current EBITDA margin is −443.56%. See more stats in XLIFE SCIENCES LTD. financial statements.
Like other stocks, XLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XLIFE SCIENCES LTD. stock right from TradingView charts — choose your broker and connect to your account.